Tenaya Therapeutics

Price & Volume

Track all markets on TradingView

Stats

See more
Open
$3.60
Previous Close
$3.29
Day Range
$2.96-$3.69
52W Range
$1.61-$7.01
Market Cap
$234.4M
Shares Short
5M

Financials

See more
Revenue (12 Mos)
$0
Revenue Growth (YoY)
0%
Gross Profit (12 Mos)
$0
Diluted EPS
-$1.44

News

See more

Yahoo Finance • last year

Tenaya Therapeutics to Participate at the 35th Annual Piper Sandler Healthcare Conference

Yahoo Finance • last year

Tenaya Therapeutics Announces FDA Clearance to Begin Clinical Testing of TN-401 Gene Therapy for the Treatment of PKP2-Associated Arrhythmogenic Right Ventricular Cardiomyopathy

Yahoo Finance • last year

Tenaya Therapeutics Presents Encouraging New Clinical and Preclinical Data from HDAC6 Inhibitor Program TN-301 for the Potential Treatment of Heart Failure with Preserved Ejection Fraction at the 2023 HFSA Annual Scientific Meeting

Yahoo Finance • last year

Tenaya Therapeutics Doses First Patient in the MyPeak-1™ Phase 1b Clinical Trial of TN-201 for the Treatment of MYBPC3-Associated Hypertrophic Cardiomyopathy

About

CEO
Mr. Faraz Ali M.B.A.
Address
171 Oyster Point Boulevard, South San Francisco, CA, United States, 94080
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
140